News Articles on 'Clinical Pharmacology & Toxicology'

Back to All Specialties


Staff Fellow/Visiting Associate: Pharmacology/Toxicology Reviewer

The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Tissues and Advanced Therapies (OTAT), Division of Clinical Evaluation and Pharmacology ...

Source: Center for Food Safety and Applied Nutrition
Published: 13 May 2021

NDA Partners Appoints Michael A. Eldon, PhD, FCP as Partner in the Firm

President Earle Martin announced today that Michael A. Eldon, PhD, FCP, former Vice President of Clinical Pharmacology at Nektar Therapeutics, has

Source: WFMZ-TV
Published: 18 May 2021

Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and

Source: Asia One
Published: 17 May 2021

Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children

For those using drugs to treat infants and children, the integration of developmental pharmacology is crucial to appropriate clinical practice ... and Medical Toxicology (G.L.K., S.M.A.-R.,

Source: The New England Journal of Medicine
Published: 13 May 2021

Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

Certara, Inc., the global leader in biosimulation, today announced the launch of its Secondary Intelligence™ software, the first and only software that quantitatively predicts the risk of adverse effects and safety issues derived from secondary pharmacology that may impede the clinical development of a drug.

Source: Nasdaq
Published: 04 May 2021

Which medications are most toxic to the liver?

A new study published in the British Journal of Clinical Pharmacology ¬provides insights on how common hospitalized patients develop liver injury from taking different medications. When ...

Source: EurekAlert!
Published: 05 May 2021

Neuroscience Research Day Features 48 Presentations

Forty-eight oral and poster presentations were showcased at the 14th annual Buffalo Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).

Source: Medicine Buffalo
Published: 17 May 2021

Masters and Ph.D. Admissions at NIPER; Apply by May 8

Those with B.Pharm; B.A.M.S; B.V.Sc; M.B.B.S; BDS, and those with B.Tech/B.E in specified branches, M.Sc in specified areas can apply for the different Master's programs. The centers where courses are available and eligibility for admission to each course at centers is given in the Master's Brochure available at For admission to Masters Programs,

Source: Mathrubhumi
Published: 08 May 2021

Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands Scientific Advisory Team

Dr. Lanctot received a BSc in Pharmacology and Toxicology, an MS in Clinical Pharmacology and a PhD in Clinical Pharmacology from the University of Toronto. About Bright Minds Bright Minds is ...

Source: Business Insider
Published: 27 Apr 2021

In the Search to Stall Aging, Biotech Startups Are Out for Blood

A handful of companies are trying vastly different approaches to spin animal studies into the next big anti-aging therapy

Source: Smithsonian Magazine
Published: 13 May 2021

Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer

We are very pleased to welcome back Dr. Teifel to Aeterna Zentaris,” commented Dr. Klaus Paulini, Chief Executive Officer of Aeterna. “He has vast knowledge and expertise, including having played an integral role for the Company previously in the development and registration of macimorelin,

Source: wallstreet online
Published: 03 May 2021

Study: Repeated vape aerosol exposure causes minimal lung damage compared to combustible cigarettes

Published in the journal Current Research in Toxicology, the experiments compared ... Fan Yu, Study Corresponding Author and Pre-Clinical Toxicologist, Imperial Brands At each puff dose, undiluted ...

Source: News Medical
Published: 06 May 2021

Adverse Effects of Voriconazole: Analysis of the French Pharmacovigilance Database

Céline Eiden, PharmD, Resident, Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France Hélène Peyrière, PharmD PhD, Lecturer in Clinical Pharmacy ...

Source: Medscape
Published: 11 May 2021

Gain Therapeutics, Inc. Reports First Quarter 2021 Financial Results

Completed successful initial public offering and raised $46 million in gross proceeds --- Appointed four new independent board of directors to strengthen leadership team ---Signed a multi-target collaboration agreement with Zentalis Pharmaceuticals (Nasdaq: ZNTL) to discover new product candidates for the treatment of cancer---Presented positive pre-clinical lysosomal storage target data at annual WorldSymposium™---Expect to complete proof of concept animal studies and begin IND-enabling trials in the second half of 2021 BETHESDA,

Source: Yahoo UK & Ireland
Published: 10 May 2021

Schrodinger Inc (SDGR) Q1 2021 Earnings Call Transcript

Q1 2021 Earnings Call May 11, 2021, 8:30 a.m. ET Thank you for standing by. Welcome to Schrodinger's conference call to review the company's first quarter financial results. My name is Kevin, and I'll be your operator for today's call.

Source: The Motley Fool on MSN.com
Published: 12 May 2021

Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the first quarter ended March 31,

Source: Associated Press
Published: 12 May 2021

Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q1 2021 Results - Earnings Call Transcript

Furthermore, we did not observe any remarkable findings in a series of non-clinical GLP toxicology and safety pharmacology studies of SPR720 including IND-enabling 28- and 31-day GLP studies both ...

Source: Seeking Alpha
Published: 09 May 2021

Inotiv, Inc. (NOTV) CEO Robert Leasure on Q2 2021 Results - Earnings Call Transcript

Bolder BioPATH adds for a scientific talent, new capabilities, expertise in non-clinical pharmacology and pathology ... major players exiting from genetic toxicology specifically, is causing ...

Source: Seeking Alpha
Published: 08 May 2021

Antengene announces completion of QSP modeling for ATG-101 in preparation for first-in-human trial

Antengene announces completion of QSP modeling for ATG-101 in preparation for first-in-human trial: Shanghai Tuesday, May 18, 2021, 18:00 Hrs [IST] Antengene Corporation Limited,

Source: Pharmabiz
Published: 18 May 2021

Gain Therapeutics, Inc. Reports First Quarter 2021

Body> Completed successful initial public offering and raised $46 million in gross proceeds <br/> --- <br/> Appointed four new independent board of directors to strengthen leadership team <br/> ---<br

Source: Middle East North Africa Financial Network
Published: 10 May 2021

Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

the first and only software that quantitatively predicts the risk of adverse effects and safety issues derived from secondary pharmacology that may impede the clinical development of a drug.

Source: Benzinga.com
Published: 04 May 2021

Certara Launches Secondary Intelligence Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

(Nasdaq: CERT), the global leader in biosimulation, today announced the launch of its Secondary Intelligence software, the first and only software that quantitatively predicts the risk of adverse effects and safety issues derived from secondary pharmacology that may impede the clinical development of a drug.

Source: wallstreet online
Published: 04 May 2021

Nimbus Therapeutics Expands Development Team to Advance Multiple Portfolio Programs Through Clinical Testing

Upadhyay joins as Vice President of Clinical Operations ... Mr. Upadhyay holds a B.S. in pharmacology and toxicology from Philadelphia College of Pharmacy and an M.S. in Quality Assurance ...

Source: Business Wire
Published: 21 Apr 2021

Biotechnology Company Centivax Officially Launches

Centivax Inc. is proud to announce its launch on Jan. 1, 2021, as a fully independent biotechnology company developing broad-spectrum therapeutics and a vaccines portfolio, including indications in COVID-19,

Source: Associated Press
Published: 29 Apr 2021

Nimbus Therapeutics Expands Development Team to Advance Multiple Portfolio Programs Through Clinical Testing

Key hires in clinical and CMC augment Nimbus' in ... Mr. Upadhyay holds a B.S. in pharmacology and toxicology from Philadelphia College of Pharmacy and an M.S. in Quality Assurance/Regulatory ...

Source: Benzinga.com
Published: 21 Apr 2021

Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801

EVT801 comes with a comprehensive pre-clinical data package, very well-characterised pharmacology ... borne metastases with a highly favourable toxicology profile. Kazia seeks to clinically ...

Source: Digital Journal
Published: 19 Apr 2021